Paratek Pharmaceuticals, Inc. (PRTK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Paratek Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.60x | -3.68x | -2.38x | -1.03x | -1.44x | -5.39x |
| P/B Ratio | -0.59x | -1.70x | -2.70x | -3.33x | 3.39x | 5.81x |
| P/S Ratio | 0.67x | 1.80x | 6.35x | 7.99x | 9.44x | 38.06x |
| Profitability | ||||||
| Gross Margin | 84.7% | 82.2% | 80.1% | 78.9% | 100.0% | 100.0% |
| Operating Margin | -30.6% | -34.0% | -173.5% | -698.9% | -608.1% | -670.4% |
| Net Margin | -42.2% | -48.8% | -267.2% | -778.5% | -656.4% | -706.0% |
| EBITDA Margin | -29.8% | -33.6% | -169.9% | -656.1% | -589.1% | -658.5% |
| Liquidity | ||||||
| Current Ratio | 3.66x | 4.86x | 6.85x | 10.06x | 14.41x | 9.56x |
| Quick Ratio | 3.22x | 4.51x | 6.24x | 9.58x | 16.80x | 9.55x |
| Leverage | ||||||
| Debt/Equity | -1.51x | -2.00x | -2.46x | -6.62x | 4.80x | 0.72x |
YoY = year-over-year change. Source: FMP..